ampelopsin has been researched along with Vascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, AF; Amin, AH; Awad, EM; El-Daly, M; El-Tahawy, NFG; Hollenberg, MD; Taye, A; Wagdy, A | 1 |
1 other study(ies) available for ampelopsin and Vascular Diseases
| Article | Year |
|---|---|
Dihydromyricetin protects against high glucose-induced endothelial dysfunction: Role of HIF-1α/ROR2/NF-κB.
Topics: Acetylcholine; Animals; bcl-2-Associated X Protein; Caspase 3; Female; Flavonols; Glucose; Glucose Transporter Type 1; Hyperglycemia; Hypoxia-Inducible Factor 1, alpha Subunit; NF-kappa B; Rats; Receptor Tyrosine Kinase-like Orphan Receptors; Tumor Necrosis Factor-alpha; Vascular Diseases | 2022 |